Type ICD36 Deficiency in Humans Is not Associated with Insulin Resistance Syndrome

Thromb Haemost 2000; 83(05): 786
DOI: 10.1055/s-0037-1613910

Letters to the Editor

Schattauer GmbH

Hidekatsu Yanai

¹From the Department of Laboratory Medicine, Hokkaido University School of Medicine, Sapporo, Japan

,

Hitoshi Chiba

¹From the Department of Laboratory Medicine, Hokkaido University School of Medicine, Sapporo, Japan

,

Mie Morimoto

²Hokkaido University College of Medical Technology, Sapporo, Japan

,

G. A. Jamieson

³American Red Cross, Rockville, Md., USA

,

Kazuhiko Matsuno

²Hokkaido University College of Medical Technology, Sapporo, Japan

References
1 Altman JA, Glazier AM, Wallace CA, Cooper LD, Norsworthy PJ, Wahid FN, Al-Majali KM, Trembling PM, Mann CJ, Shoulders CC, Graf D, St Lezin E, Kurtz TW, Kren V, Pravenec M, Ibrahimi A, Abumrad NA, Stanton LW, Scott J. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nature Genet 1999; 21: 76-83.
2 Yamamoto N, Akamatsu H, Sakuraba H, Yamazaki H, Tanoue K. Platelet glycoprotein IV (CD36) deficiency is associated with the absence (type I) or the presence (type II) of glycoprotein IV on monocytes. Blood 1994; 83: 392-7.
3 Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
4 Watanabe K, Ohta Y, Toba K, Ogawa Y, Hanawa H, Hirokawa Y, Kodama M, Tanabe N, Hirono S, Ohkura Y, Nakamura Y, Kato K, Alzawa Y, Fuse I, Miyajima S, Kusano Y, Nagamoto T, Hasegawa G, Naito M. Myocardial CD36 expression and fatty acid accumulation in patients with type I and II CD36 deficiency. Ann Nucl Med 1998; 12: 261-6.